News

The double-blind, multicenter, placebo-controlled, randomized study is designed to assess the safety, tolerability, and efficacy of AVP-923. The primary efficacy endpoint will be measured based on the Numeric

As part of the agreement, Celgene, which will commit $45M to Quanticel during alliance term, will acquire an equity stake in Quanticel and will retain an option to

The rights include ATN-103 and PF-05230905 products. Ablynx will also acquire Pfizer intellectual property and know-how with regarding to the anti-TNF-alpha programmes and will have access to Pfizer’s

The study also confirmed that inhibition of miR-15 can save cardiomyocytes from death during myocardial infarction. MiRagen Therapeutics president and CEO William S Marshall said that the data

The open-label, multiple-dose, dose-escalation study will also assess the impact of SNS01-T on time to relapse or progression and tumor response using multiple metrics. Senesco president and CEO

Qnexa is a once-a-day, oral investigational drug candidate which treats weight loss, type 2 diabetes and obstructive sleep apnea. FDA assigned a six-month, or class 2, review classification

APC-100 prevents the occurrence or recurrence of prostate cancer, the company claims. The drug is an orally available anti-androgenic/anti-inflammatory, signal transduction inhibitor which is said to have high

The funding is intended for improvements in manufacturing facility. Aoxing Pharma Chairman and CEO Zhenjiang Yue said the company is happy for the continued support from the government

GMOL is used in China to treat brain ischemia and infarction, coronary heart diseases, memory dysfunction and other neurological disorders. Gingko extracts mainly comprise flavonoids and terpenoids. Flavonoids